Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Renal biopsy in light chain cast nephropathy

Blood (2020) 135 (21): 1917.

https://doi.org/10.1182/blood.2020006410

Published: 2020

Journal Articles

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study

Blood (2020) 135 (21): 1833–1846.

https://doi.org/10.1182/blood.2019003807

Published: 2020

Includes: Supplemental data

Journal Articles

Renal Pathology in Patients with Monoclonal Gammopathy or Multiple Myeloma: Monoclonal Immunoglobulins Are Not Always the Cause

Eftathios Kastritis, Nikolaos Kanellias, MD, Foteini Theodorakakou, MD, Erasmia Psimenou, MD, Charikleia Gakiopoulou, MD, Smaragdi Marinaki, Maria Roussou, MD, Maria Gavriatopoulou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 1776.

https://doi.org/10.1182/blood-2019-126385

Published: 2019

Journal Articles

Clinically Suspected Cast Nephropathy: A Retrospective, Multi-Center, Real-World Study

Agoston Gyula Szabo, MD, Jonathan Thorsen, MD PhD, Charlotte Toftmann Hansen, MD PhD, Maja Ølholm Vase, MD PhD, Manuela Teodorescu, MD, Simon Bo Pedersen, MD, Simon Bertram Flæng, MD, Ulf Christian Frølund, MD, Annette Juul Vangsted, MD PhD, Torben Plesner, MD DSc

Blood (2019) 134 (Supplement_1): 5553.

https://doi.org/10.1182/blood-2019-124336

Published: 2019

Journal Articles

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Florent Joly, Camille Cohen, Vincent Javaugue, Sébastien Bender, Mohamed Belmouaz, Bertrand Arnulf, Bertrand Knebelmann, Mathilde Nouvier, Vincent Audard, François Provot, Viviane Gnemmi, Dominique Nochy, Jean Michel Goujon, Arnaud Jaccard, Guy Touchard, Jean Paul Fermand, Christophe Sirac, Frank Bridoux

Blood (2019) 133 (6): 576–587.

https://doi.org/10.1182/blood-2018-09-872028

Published: 2019

Includes: Supplemental data

Journal Articles

18 f-Fludeoxyglucose and 11 c-Methionine PET/CT Scans in Patients with Multiple Myeloma Following Autologous Stem-Cell Transplantation (auto-HSCT)

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Maiia V. Firsova, MD PhD, Irakly P. Aslanidi, Olga V. Mukhortova, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3433.

https://doi.org/10.1182/blood-2018-99-112886

Published: 2018

Journal Articles

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Yoshiaki Abe, Tetsuya Kobayashi, MD, Kentaro Narita, MD, Hiroki Kobayashi, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 4478.

https://doi.org/10.1182/blood-2018-99-110064

Published: 2018

Journal Articles

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Blood (2018) 132 (Supplement 1): 1966.

https://doi.org/10.1182/blood-2018-99-112851

Published: 2018

Journal Articles

Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement

Benjamin Diamond, MD, David S Jayabalan, MSc, Roger Pearse, MD PhD, Art Perry, Karen Pekle, Ruben Niesvizky, MD, Adriana C. Rossi, MDMSc

Blood (2017) 130 (Supplement 1): 3102.

https://doi.org/10.1182/blood.V130.Suppl_1.3102.3102

Published: 2017

Journal Articles

Plasmapheresis and Myeloma Cast Nephropathy: A Meta-Analysis and Review of Evidence

Yaser Alkhatib, Aliakbar Dadla, MD, Devin Malik, MD, Zaid Abdel-Rahman, MD, Philip Kuriakose, MD, Vrushali S. Dabak, MD, Vijayalakshmi Donthireddy

Blood (2017) 130 (Supplement 1): 5415.

https://doi.org/10.1182/blood.V130.Suppl_1.5415.5415

Published: 2017

Journal Articles

Characteristics of Light Chain Deposition Disease (LCDD) and Factors Affecting Outcome after Treatment

Jameel Muzaffar, MD, Abdullah Mohammad Khan, MBBS,MSc, Athira Unnikrishnan, MD, Preeti Narayan, MD, Dara Wakefield, MD, Jan S Moreb, MD

Blood (2017) 130 (Supplement 1): 5513.

https://doi.org/10.1182/blood.V130.Suppl_1.5513.5513

Published: 2017

Journal Articles

Rapid Removal of Myeloma Light Chains By Continuous Veno-Venous Hemofiltration in a Patient with Acute Cast Nephropathy As a Result of Lambda Light Chain Myeloma

Brett L. Gourley, MD, Elizabeth Bengtson, MD, Mark Cervinski, MD

Blood (2017) 130 (Supplement 1): 5426.

https://doi.org/10.1182/blood.V130.Suppl_1.5426.5426

Published: 2017

Journal Articles

Response-Adapted Therapy for Newly Diagnosed Myeloma

Frederic J. Reu, MD, Tomas Radivoyevitch, PhD, Jason Valent, MD, Chad Cummings, MBA, Katherine Tullio, MPH, MS, Debbie Hastings, Beth M Faiman, PhD RN, MSN, CNP, AOCN, Kimberly Hamilton, CNP, Janice Reed, RN, Mary Ann Karam, RN, Matt Kalaycio, MD FACP, Hien K. Liu, MD, Christy Samaras, DO, Brian J. Bolwell, MD, Mitchell R. Smith

Blood (2016) 128 (22): 3606.

https://doi.org/10.1182/blood.V128.22.3606.3606

Published: 2016

Journal Articles

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Akhil Khera, Katja Kimberger, Fotios Panitsas, Chris Winearls, John Quinn, Simon Stern, Neil Rabin, Bassam Alchi, Ian Roberts, Richard Haynes, Karthik Ramasamy

Blood (2016) 128 (22): 5948.

https://doi.org/10.1182/blood.V128.22.5948.5948

Published: 2016

Journal Articles

Successful Renal Transplant Tolerance Following a Haplo-Identical Allogenic Hematopoietic Stem Cell Transplant - a Case Report and Review of Literature

Neil Shah, MD, Adam S. Vesole, BBA, Michele L. Donato, MD, David S. Siegel, MD PhD, Joshua R. Richter, MD, Noa Biran, MD, Alan P Skarbnik, MD, Robert Korngold, PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD

Blood (2016) 128 (22): 5879.

https://doi.org/10.1182/blood.V128.22.5879.5879

Published: 2016

Journal Articles

Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT))

Frank Bridoux, MD PhD, Brigitte Pegourie, MD, Karine Augeul-Meunier, MD, Bruno Royer, MD, Bertrand Joly, MD, Thierry Lamy, MD PhD, Brigitte Kolb, Lofti Benboubker, Bertrand Arnulf, MD, Arnaud Jaccard, MD PhD, Sylvie Chevret, Jean-Paul Fermand, MD

Blood (2016) 128 (22): 978.

https://doi.org/10.1182/blood.V128.22.978.978

Published: 2016

Journal Articles

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

Josephine M. Vos, MD, Robert R Manning, Kirsten Meid, MPH, Joshua Gustine, MPH, Christopher J Patterson, MFA, Philip Brodsky, Sandra Kanan, NP, RN, MSN, Marie José Kersten, MD PhD, Steven P Treon, MD PhD, Jorge J Castillo, MD

Blood (2015) 126 (23): 3926.

https://doi.org/10.1182/blood.V126.23.3926.3926

Published: 2015

Journal Articles

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Heinz Ludwig, Univ. Prof. Dr., Elisabeth Rauch, Thomas Kuehr, MD, Adam Zdenek, MD, Adalbert Weissmann, MD, Hedwig Kasparu, MD, Eva-Maria Autzinger, MD, Daniel Heintel, MD, Richard Greil, MD, Wolfram Poenisch, MD, Niklas Zojer, MD, Ercan Müldür, MD

Blood (2014) 124 (21): 3484.

https://doi.org/10.1182/blood.V124.21.3484.3484

Published: 2014

Journal Articles

Serum Free Light Chain Assays in the Early Detection of Cast Nephropathy in Patients Presenting with Unexplained Acute Kidney Injury (AKI): Results from a Pharmacoeconomic Evaluation

Mark Cook, PhD FRCPath, Paul Cockwell, Christine Almond, Holly Cranmer, Stephen Harding, MDPhD, Richard Hughes, Chris Knight, Alexander Hirst

Blood (2014) 124 (21): 2612.

https://doi.org/10.1182/blood.V124.21.2612.2612

Published: 2014

Journal Articles

Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy

Mayur Narkhede, MD, Jason Valent, MD, Chad Cummings, MBA, Katherine Glass, MPH, MS, Debbie Hastings, Beth Faiman, PhD, CNP, Kimberly Hamilton, CNP, Janice Reed, RN, Mary Ann Karam, RN, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Mitchell R. Smith, MD PhD, Hien K. Duong, MD, Christy Samaras, DO, Frederic J. Reu, MD

Blood (2014) 124 (21): 2620.

https://doi.org/10.1182/blood.V124.21.2620.2620

Published: 2014

NARROW

Renal biopsy in light chain cast nephropathy

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study

Renal Pathology in Patients with Monoclonal Gammopathy or Multiple Myeloma: Monoclonal Immunoglobulins Are Not Always the Cause

Clinically Suspected Cast Nephropathy: A Retrospective, Multi-Center, Real-World Study

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

18 f-Fludeoxyglucose and 11 c-Methionine PET/CT Scans in Patients with Multiple Myeloma Following Autologous Stem-Cell Transplantation (auto-HSCT)

N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Is Associated with Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement

Plasmapheresis and Myeloma Cast Nephropathy: A Meta-Analysis and Review of Evidence

Characteristics of Light Chain Deposition Disease (LCDD) and Factors Affecting Outcome after Treatment

Rapid Removal of Myeloma Light Chains By Continuous Veno-Venous Hemofiltration in a Patient with Acute Cast Nephropathy As a Result of Lambda Light Chain Myeloma

Response-Adapted Therapy for Newly Diagnosed Myeloma

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Successful Renal Transplant Tolerance Following a Haplo-Identical Allogenic Hematopoietic Stem Cell Transplant - a Case Report and Review of Literature

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Serum Free Light Chain Assays in the Early Detection of Cast Nephropathy in Patients Presenting with Unexplained Acute Kidney Injury (AKI): Results from a Pharmacoeconomic Evaluation

Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only